Generic ALK Inhibitor 150mg Capsule

Ceritinib is an inhibitor that blocks a protein called anaplastic lymphoma kinase (ALK), especially in a type of lung cancer known as ALK-positive NSCLC, where this protein is overproduced. It’s used for treating a stage of lung cancer called metastatic NSCLC, which has a specific ALK mutation. The main ingredient in Ceritinib comes in capsule form, each one weighing 150 mg.

Doctors usually suggest adults take 450 mg of Ceritinib once a day, and if possible, with something to eat. Each bottle holds 70 capsules. The capsules are meant to be taken by mouth and not broken apart.

You keep taking the medicine as long as it’s helping and you don’t have any bad side effects or your cancer doesn’t get any worse.